Wed, Sep 17, 2014, 2:55 AM EDT - U.S. Markets open in 6 hrs 35 mins

Recent

% | $
Quotes you view appear here for quick access.

Aradigm Corporation Message Board

kgrichard5 113 posts  |  Last Activity: Sep 15, 2014 12:54 PM Member since: Feb 9, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Bio Tech and Pharma stock sell off

    by kgrichard5 Sep 15, 2014 12:45 PM
    kgrichard5 kgrichard5 Sep 15, 2014 12:54 PM Flag

    Accept for if you are fortunate enough AVNR (which I am Not)...up 60%

  • Most of my bio techs are down...not SRPT specific, but still no fun to watch. The Pharma and Bio tech indexes (ETF's) are sharply down.

    Biotechnology companies shares down at 10 a.m.

    .

    Associated Press

    2 hours ago









    .

    .

    ..
    .
    .



    Related Stories

    Final Glance: Biotechnology companies Associated Press
    Early Glance: Education companies Associated Press
    Early Glance: Managed Care companies Associated Press
    Early Glance: Computer companies Associated Press
    Early Glance: Tools and Appliances companies Associated Press

    NEW YORK (AP) -- Shares of some top biotechnology companies are down at 10 a.m.:

    Amgen Inc. fell $.84 or .6 percent, to $137.05.

    Biogen Idec fell $5.40 or 1.7 percent, to $317.99.

    Celgene Corp. fell $2.34 or 2.6 percent, to $89.18.

    Gilead Sciences Inc. fell $2.86 or 2.8 percent, to $100.80.

  • Today's sell off is not SRPT specific. Almost all off my bio techs are down 3 to 10%. Also, biotech index is sharply down.

    Biotechnology companies shares down at 10 a.m.

    .

    Associated Press

    2 hours ago









    .

    .

    ..
    .
    .



    Related Stories

    Final Glance: Biotechnology companies Associated Press
    Early Glance: Education companies Associated Press
    Early Glance: Managed Care companies Associated Press
    Early Glance: Computer companies Associated Press
    Early Glance: Tools and Appliances companies Associated Press

    NEW YORK (AP) -- Shares of some top biotechnology companies are down at 10 a.m.:

    Amgen Inc. fell $.84 or .6 percent, to $137.05.

    Biogen Idec fell $5.40 or 1.7 percent, to $317.99.

    Celgene Corp. fell $2.34 or 2.6 percent, to $89.18.

    Gilead Sciences Inc. fell $2.86 or 2.8 percent, to $100.80.

  • Reply to

    New week.. anything on the slate?

    by tfworl Sep 15, 2014 7:46 AM
    kgrichard5 kgrichard5 Sep 15, 2014 8:48 AM Flag

    Meeting with the FDA this week or next....if on schedule. This will give more clarity to the NDA timeline and probability for success.

  • Reply to

    WMC Medical Supplies & Consultancy

    by andy55q Sep 13, 2014 4:31 PM
    kgrichard5 kgrichard5 Sep 15, 2014 8:27 AM Flag

    Agreed. There have been a lot of catalysts that have been projected for this year, Chan is behind on delivering....HemoDefend, partnerships, new products, interim data, FDA trial design etc.......However, the only projection I hope he is late on (at least at this juncture), is the R/S up list.

  • I hope we can accompliishing garnering institutional investors through organic growth. However...per below discussion:
    The problem is when you are conceding to a buffer, you are essentially embracing a post sell off R/S. You go to 2 or 5 (what ever) and want to hold 1 or 3 without substantive maintenance/growth data/partnership amo to prohibit the post R/S sell off. This happens a lot in up listing. I usually always keep dry powder for a subsequent ell off post R/s Up list. The street knows when you are over extending your up list only to be able to maintain it for 30 consecutive days (example). Punit needs to be smart and about his pps targets. Targets that will bring in institutional investors, not traders, which is what the R/S...up list is strategically designed to do

  • Reply to

    More selling to continue next week

    by stilllondgo Sep 12, 2014 4:25 PM
    kgrichard5 kgrichard5 Sep 12, 2014 4:56 PM Flag

    Thanks for the heads up. If you are successful, I will buy the new bottom. Your help in accumulating at bargain prices is appreciated....the prize is 6 to 9 months out. Have a great weekend.

  • kgrichard5 kgrichard5 Sep 12, 2014 3:24 PM Flag

    AMRN???? What are you smoking? I have no clue what you are talking about. This is the RNN board.....Hello

  • kgrichard5 kgrichard5 Sep 12, 2014 10:19 AM Flag

    I know Jet. He's the real deal and his intent is always genuine and sincere. He is also very qualified. He would be the first to admit these bio techs are risky, but he does his DD. He is the investment founder of ISIS. BTW, Jet, been in the river slamin salmon?

  • Reply to

    today Gary?

    by longandstrong1357 Sep 12, 2014 6:58 AM
    kgrichard5 kgrichard5 Sep 12, 2014 10:13 AM Flag

    I settle it....250 : )

  • kgrichard5 kgrichard5 Sep 12, 2014 9:40 AM Flag

    Thumbs up post. IMSC also traveled with our Government recently. Why would they create an alliance with a company they do not see value in. American made, high risk environment, Government supported, easy, safe and effective technology, motivated and competent management team, product needed around the ENTIRE world for a massive market, commercial and government market, credentialed and much more to come. I am still a buyer below 2. GLTA

  • Reply to

    With $237,500* in the game

    by greenplanet2014 Sep 11, 2014 2:13 PM
    kgrichard5 kgrichard5 Sep 12, 2014 9:25 AM Flag

    You must be a multi-millionaire to put that much money into this lottery. I wish you well. I am down to a measly 140,000 shares. After 6 years and 6 different technologies/platforms they have basically NO revenue, billions of diluted OS and essentially two employees. No, I am not adding. I always wish any investor well. I hate bashers and jealous sideliners when something finally comes to fruition...so I am sincere when I say I hope this hits 5 plus dollars some day. How long have you been in this stock? Just curious.

  • Reply to

    today Gary?

    by longandstrong1357 Sep 12, 2014 6:58 AM
    kgrichard5 kgrichard5 Sep 12, 2014 9:05 AM Flag

    I agree. Gary is the ultimate optimist, but if he has as many shares as he claims he has, he is backing his DD conviction and hope, with shares. He also contributes by digging up some hidden DD gems at times.. I have been here for 12 plus years....I wish Gary and the rest of us mega longs success. I hope some day, Gary's "Today will be the day".....will be the day!

  • Reply to

    ROTH has offering posted at 1.30 for Monday

    by saulirosenberg Sep 5, 2014 4:36 PM
    kgrichard5 kgrichard5 Sep 6, 2014 9:11 AM Flag

    Bridestone 7's in the warm air...350 yards baby.....but not straight....still provides for nature viewing deep into the woods!

  • Reply to

    At the sidekline now

    by evertjan.puttman Sep 6, 2014 6:15 AM
    kgrichard5 kgrichard5 Sep 6, 2014 8:20 AM Flag

    I am 50% with you on your strategy. I may sell additional shares if the presentations show more fluff than substance. In January there was a boat load of hype regarding multiple catalysts and very very little has happened. I am also not satisfied with the sales trajectory and traction Q over Q at this juncture. If Chan delivers in these last few months of the year, then we may regret sitting on the sidelines. I am also concerned about a premature R/S, without ammunition to support and sustain it. I also believe in the potential of this company, but despise over expectation based CEO's I am also supportive of the patient longs, they are usually the 10 bag winners. I bought ISIS at 4 bucks, and got inpatient and sold in the mid teens and then on further pull backs. Other longs stayed the course and came in with me at 4 and sold at 62.

  • Reply to

    Micheal Wong un reachable

    by daveatmel Sep 5, 2014 3:33 PM
    kgrichard5 kgrichard5 Sep 5, 2014 4:00 PM Flag

    Maybe he is in the back room meeting with the FDA as we speak.

  • Reply to

    Stock futures good

    by usagary1 Sep 3, 2014 9:26 AM
    kgrichard5 kgrichard5 Sep 3, 2014 2:54 PM Flag

    “Despite tremendous efforts from the U.S. Government, from CDC, from within countries, the number of cases continues to increase and is now increasing rapidly. I’m afraid over the next few weeks, those numbers are likely to increase further and significantly. There is a window of opportunity to tamp this down, but that window is closing. We need action now to scale up the response. We know how to stop Ebola. The challenge is to scale it up to the massive levels needed to stop this outbreak.”

  • Reply to

    ODDS

    by greyzone513 Sep 1, 2014 11:11 PM
    kgrichard5 kgrichard5 Sep 3, 2014 8:00 AM Flag

    Just be careful with the zero toxicity statement going forward. I have seen dozens of drugs ( I was a Pharmaceutical rep) for 27 years, get pulled. This was after phase1, 2 phase 2's, 2 phase 3's, then post approval with concomitant phase 4 follow up to the open market masses. Some, post approval weeks, others months and years the liver, heart etc... reared it's ugly head. Thousands of patient year exposure, collectively through the approval and post approval process. Eteplirsen looks clean and I hope like many meds can retain that status with huge numbers going forward. And yes, the side effect of NOT taking Etep has a "zero" stat associated with it also...no..regression, disability, and eventual death.

  • Reply to

    PS - I'm very LONG ONCS

    by tdhand2003 Sep 1, 2014 9:40 AM
    kgrichard5 kgrichard5 Sep 1, 2014 10:27 AM Flag

    It's because getting 5 to 10 percent per year won't allow for early retirement.....a 10 bagger will! If you hate your job, this is a lottery ticket out perhaps. Then again, 20 years from now, the 5 to 10% approach could very well look quite astute. As for now, I would rather be financially independent. Also, it may only be 5% of his total portfolio. I am answering for him, because I ask myself the same question you are asking him. The risk/reward scenario is different for everyone. This is a very risky play with only one product and phase 2 limited number of patients.

  • kgrichard5 kgrichard5 Aug 29, 2014 3:16 PM Flag

    Sad when we are happy with half the value pre ASCO. Post ASCO we deliver the data and lose half our value.

ARDM
10.43+0.35(+3.47%)Sep 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.